Liminatus Pharma, Inc. LIMN
2.81 USD +0.10 (+3.69%)
Regular-session close
3.27 +0.46 +16.23%
Pre-market · Nov 20, 5:21 AM ET
2.70 Day range 3.00
2.40 52-week range 141.50
- YTD
- -90.79%
- 1 year
- -94.98%
5D -0.10 (-3.44%)
- Market cap
- 3.77M
- EPS (ttm)
- -23.50
- YTD return
- -90.79%
- 1-year return
- -94.98%
- Volume
- 50.66K
- Avg volume
- 32.06K
- Open
- 2.94
- Previous close
- 2.71
- Day's range
- 2.70 – 3.00
- 52-week range
- 2.40 – 141.50
Fundamental scorecard
3 of 25 checks passed on LIMN’s reported financials
3of 25 checks passed
- Value 0 of 5
- Growth 0 of 5
- Profitability 0 of 5
- Financial health 3 of 5
- Dividend 0 of 5
Statements to Jun 30, 2026.
Financials — quick view
LIMN Revenue — quarterly 0
LIMN Net income — quarterly -1.41M
LIMN EPS — quarterly -1.50
News
Your note
Sign in to keep a note on LIMN — it syncs with the Stock Master app.
